Navigation Links
Cancer Drug Helps An Anti-Cancer Virus To Act More Exhaustively

ust this early immune response, making it unnecessary to totally suppress the immune system when using this treatment.'

In the late 1990s, a student of Chiocca's discovered that the virus killed tumours more effectively when the animals were first given the drug. Chiocca then set out to learn why.

In this study, one of Chiocca's fellows, Giulia Fulci, now at Massachusetts General Hospital in Boston, examined brains from rats treated with the virus, with and without the drug to identify the immune cells present in the tumour before injection of the virus, and at different times afterward.

Six hours after the injection of the virus, she found that high numbers of NK cells, macrophages and brain-tissue immune cells called microglia had moved into the tumour. The number of macrophages, for example, had raised three fold. In animals given the drug, on the other hand, the number of these immune cells increased by only one half.

Other experiments performed together with Michael A. Caligiuri, director of the OSU Comprehensive Cancer Centre, revealed that when the drug is added to NK cells growing in the laboratory, the cells stop making an immune substance called interferon gamma (IFNg). One key effect of IFNg is to attract immune cells to an infection site. The production of the substance could therefore intensify the immune response against the anti-cancer virus.

Furthermore the researchers found that in rat brain tumours treated with the virus but not with the drug, IFNg levels rose by 10 times after six hours and by more than 120 times after 72 hours. Animals given the drug showed only small increases of IFNg.

Lastly, the researchers tested the treatment in brain tumours in mice that cannot make IFNg. They found that viral genes were expressed much more in these animals.

Overall, the study suggests that cyclophosphamide improves the cancer-killing ability of this virus by inhibiting the
'"/>




Page: 1 2 3

Related medicine news :

1. Fibroids unlikely to Turn Cancerous
2. Virus Level could Predict Cervical Cancer Risk
3. Cancer Doctors Okays Controversial Prostate Therapy
4. Potential New Cancer Gene Identified
5. Consensus on "Combination Therapy" for Breast Cancer
6. Cancers of Colon & Rectum linked to Cigarette Smoking
7. Life Saving Cancer Drugs – From Chicken! Possible Says Dolly’ Creatos
8. The Cancer Rumour mill working over time
9. Cancer drugs in development nearly doubled since 1995
10. Radioactive Seeds used in Prostate Cancer treatment can migrate with the body
11. Cancer patients turning to Internet for information
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Cancer Drug Helps Anti Cancer Virus Act More Exhaustively

(Date:4/14/2014)... orphaned by HIV/AIDS in South Africa may provide insight ... behavior issues in other areas of the world, which ... that could lead to successful interventions. , A ... United Nations mentions that due to the HIV/AIDS pandemic, ... African, children are at an increased risk for mental ...
(Date:4/14/2014)... A new study shows that moderate to severe ... risk of stroke, cancer and death. , Results of ... to severe obstructive sleep apnea were four times more ... times more likely to have a stroke (HR = ... (HR = 3.4), and 2.5 times more likely to ...
(Date:4/14/2014)... Dallas study involving serious youth offenders, the answer to one ... seven years: "How long do you think you,ll live?", According ... offending over time., Author Dr. Alex Piquero said the study ... of them offend at very high rates and commit more ... much later in life offend much less., "In a lot ...
(Date:4/14/2014)... with symptoms increasing dramatically during some of the most important ... has found. , Depressive symptoms increased on average by 68 ... young men, who were around 25 years old when they ... their children. The results of the study were published April ... is the first to identify when young fathers are at ...
(Date:4/14/2014)... Lower weight babies and babies who aren,t breastfed ... risk of developing chronic inflammation and related health ... study. , "There were good reasons to hypothesize ... inflammation in adulthood," says Thomas McDade (Northwestern University), ... in the Child & Brain Development program. "It ...
Breaking Medicine News(10 mins):Health News:Researchers identify children with emotional behavior difficulties 2Health News:Researchers identify children with emotional behavior difficulties 3Health News:Study links severe sleep apnea to increased risk of stroke, cancer and death 2Health News:UT Dallas study: Youth who fail to envision future commit more crimes 2Health News:Young dads at high risk of depression, too 2Health News:Low birth weight, less breastfeeding create later health risks 2
... Morning Show On 101.9fm THE MIX/WTMX ... Will Be Event Host and Emcee, GURNEE, Ill., Oct. 2 ... one local boy, Jake Robert Widman, of Gurnee, won,t be,blowing out the ... of pediatric cancer called neuroblastoma on May 27, 2005, when he was,just ...
... and treatment of low-back pain has prompted the American ... (ACP) to issue a new treatment guideline. The guideline ... conducted by investigators at the Oregon Evidence-Based Practice Center ... recommendations issued by a panel of experts convened by ...
... to sudden cardiac death , TUESDAY, Oct. 2 ... perindopril, along with a beta blocker, may help ... Marfan syndrome, research shows. , Marfan syndrome, which ... excessive bone elongation and joint flexibility, and eye ...
... Calif., Oct. 2 Angel Flight West (AFW),awarded The ... at,AFW,s 24th Anniversary Awards on Saturday, September 29. Dr. ... year. As an AFW,pilot, he flies people in need ... and from medical facilities. Dr. Irish, like,all AFW volunteer ...
... gamma imaging for both ... NEWPORT NEWS, Va., Oct. 2 Recently published ... Gamma Imaging,(BSGI) may be more specific than MRI ... compiled by Dr. Rachel Brem and,colleagues at The ...
... 2 Aflac today announced,that Jeffrey M. Herbert ... officer of the company,s U.S. insurance operation. Herbert ... for his departure from the,company. (Logo: ... Aflac president and chief,operating officer for Aflac U.S., ...
Cached Medicine News:Health News:Super Jake Foundation Hosts 3rd Annual 'Heroes Bash' on Nov. 3 to Benefit Pediatric Cancer Research 2Health News:Super Jake Foundation Hosts 3rd Annual 'Heroes Bash' on Nov. 3 to Benefit Pediatric Cancer Research 3Health News:New clinical guideline for low-back pain 2Health News:New clinical guideline for low-back pain 3Health News:Drug Combo Helps Fight Marfan Syndrome 2Health News:Angel Flight West Recognizes Colorado Pilots and Supporters at AFW 24th Anniversary Awards 2Health News:Study Determines Breast-Specific Gamma Imaging Has Higher Specificity Than MRI in Patients With Equivocal Mammograms 2Health News:Study Determines Breast-Specific Gamma Imaging Has Higher Specificity Than MRI in Patients With Equivocal Mammograms 3Health News:Aflac Announces Resignation of U.S. Marketing Officer 2Health News:Aflac Announces Resignation of U.S. Marketing Officer 3
(Date:1/15/2014)... Mass. , Jan. 15, 2014  Zafgen, ... the unmet needs of severely obese patients, today ... of beloranib, a selective inhibitor of methionine aminopeptidase ... a severe form of genetic obesity.  These results ... body composition, including reductions in body fat content ...
(Date:1/14/2014)... BEVERLY HILLS, Calif. , Jan. 14, 2014 ... , offers Los Angeles a premier ... Duality laser and a $99 treatment special. Dr. Brandeis, focus ... medical technology and offering expert medical advice to all patients. ... a dramatic increase in the presence of tattoo regret and ...
(Date:1/14/2014)... 2014 NineSigma , Inc., the leading ... Innovation Leadership Summit , May 14-16, 2014 at the ... Ohio . This is the ... to breakthrough achievements through open innovation. Participants will learn ... across disciplines and even across industries. ...
Breaking Medicine Technology:Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 2Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 3Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 4Beverly Hills Physician Features Tattoo Removal with the Astanza Duality Laser, Offers $99 Special 2Expect the Unexpected from Leading Global Innovators at NineSigma Leadership Summit, Sharing Winning Strategies to Advance Innovation 2Expect the Unexpected from Leading Global Innovators at NineSigma Leadership Summit, Sharing Winning Strategies to Advance Innovation 3Expect the Unexpected from Leading Global Innovators at NineSigma Leadership Summit, Sharing Winning Strategies to Advance Innovation 4
... WINDSOR, N.J. , July 7 ITelagen, a leading ... it was selected by Zweena, LLC of West Windsor, NJ ... ITelagen, which was selected for its expertise in EHR management, is ... solution. , , , ...
... DENVER , July 7 Invision Sally Jobe ... a new breast ultrasound technology for the early detection of cancer. Screening ... in women with radiologically dense breasts and other risk factors. , ... "Screening breast ultrasound is part ...
Cached Medicine Technology:Zweena Selects ITelagen to Host Personal Health Records Application 2Zweena Selects ITelagen to Host Personal Health Records Application 3Invision Sally Jobe Introduces New Breast Cancer Screening Technology to Denver 2Invision Sally Jobe Introduces New Breast Cancer Screening Technology to Denver 3Invision Sally Jobe Introduces New Breast Cancer Screening Technology to Denver 4
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: